These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
263 related articles for article (PubMed ID: 30244085)
1. Galactosylated chitosan triptolide nanoparticles for overcoming hepatocellular carcinoma: Enhanced therapeutic efficacy, low toxicity, and validated network regulatory mechanisms. Zhang YQ; Shen Y; Liao MM; Mao X; Mi GJ; You C; Guo QY; Li WJ; Wang XY; Lin N; Webster TJ Nanomedicine; 2019 Jan; 15(1):86-97. PubMed ID: 30244085 [TBL] [Abstract][Full Text] [Related]
2. Triptolide-loaded nanoparticles targeting breast cancer in vivo with reduced toxicity. Zheng W; Wang C; Ding R; Huang Y; Li Y; Lu Y Int J Pharm; 2019 Dec; 572():118721. PubMed ID: 31626922 [TBL] [Abstract][Full Text] [Related]
3. Application of galactosylated albumin for targeted delivery of triptolide to suppress hepatocellular carcinoma progression through inhibiting de novo lipogenesis. Yu L; Qian J; Xue X; Pang M; Wang X; Li X; Tian M; Lu C; Xiao C; Liu Y Biomed Pharmacother; 2024 Oct; 179():117432. PubMed ID: 39255735 [TBL] [Abstract][Full Text] [Related]
4. Comparison of toxicokinetic and tissue distribution of triptolide-loaded solid lipid nanoparticles vs free triptolide in rats. Xue M; Zhao Y; Li XJ; Jiang ZZ; Zhang L; Liu SH; Li XM; Zhang LY; Yang SY Eur J Pharm Sci; 2012 Nov; 47(4):713-7. PubMed ID: 22677813 [TBL] [Abstract][Full Text] [Related]
5. Triptolide-nanoliposome-APRPG, a novel sustained-release drug delivery system targeting vascular endothelial cells, enhances the inhibitory effects of triptolide on laser-induced choroidal neovascularization. Lai K; Li Y; Gong Y; Li L; Huang C; Xu F; Zhong X; Jin C Biomed Pharmacother; 2020 Nov; 131():110737. PubMed ID: 32932044 [TBL] [Abstract][Full Text] [Related]
6. Homotypic cell membrane-camouflaged biomimetic PLGA nanoparticle loading triptolide for the treatment of hepatocellular carcinoma. Li Z; Lan J; Wu Y; Ding Y; Zhang T Drug Deliv; 2024 Dec; 31(1):2354687. PubMed ID: 38823413 [TBL] [Abstract][Full Text] [Related]
7. Triptolide-targeted delivery methods. Xu H; Liu B Eur J Med Chem; 2019 Feb; 164():342-351. PubMed ID: 30605832 [TBL] [Abstract][Full Text] [Related]
8. Inhibition of Cancer Angiogenesis Using Triptolide Nanoparticles. Wang C; Shan Y; Yang J; Xu X; Zhuang B; Fan Y; Xu W J Biomed Nanotechnol; 2015 May; 11(5):805-15. PubMed ID: 26349393 [TBL] [Abstract][Full Text] [Related]
9. Combination of metronomic administration and target delivery strategies to improve the anti-angiogenic and anti-tumor effects of triptolide. Cai XJ; Fei WD; Xu YY; Xu H; Yang GY; Cao JW; Ni JJ; Wang Z Drug Deliv Transl Res; 2020 Feb; 10(1):93-107. PubMed ID: 31418132 [TBL] [Abstract][Full Text] [Related]
10. Fabrication of a triptolide-loaded and poly-γ-glutamic acid-based amphiphilic nanoparticle for the treatment of rheumatoid arthritis. Zhang L; Chang J; Zhao Y; Xu H; Wang T; Li Q; Xing L; Huang J; Wang Y; Liang Q Int J Nanomedicine; 2018; 13():2051-2064. PubMed ID: 29670349 [TBL] [Abstract][Full Text] [Related]
11. Membrane protein-chimeric liposome-mediated delivery of triptolide for targeted hepatocellular carcinoma therapy. Zheng Y; Kong F; Liu S; Liu X; Pei D; Miao X Drug Deliv; 2021 Dec; 28(1):2033-2043. PubMed ID: 34569906 [TBL] [Abstract][Full Text] [Related]
12. Kidney-targeted triptolide-encapsulated mesoscale nanoparticles for high-efficiency treatment of kidney injury. Deng X; Zeng T; Li J; Huang C; Yu M; Wang X; Tan L; Zhang M; Li A; Hu J Biomater Sci; 2019 Dec; 7(12):5312-5323. PubMed ID: 31617509 [TBL] [Abstract][Full Text] [Related]
13. Novel CD44-targeting and pH/redox-dual-stimuli-responsive core-shell nanoparticles loading triptolide combats breast cancer growth and lung metastasis. Shi J; Ren Y; Ma J; Luo X; Li J; Wu Y; Gu H; Fu C; Cao Z; Zhang J J Nanobiotechnology; 2021 Jun; 19(1):188. PubMed ID: 34162396 [TBL] [Abstract][Full Text] [Related]
14. Development of triptolide-nanoemulsion gels for percutaneous administration: physicochemical, transport, pharmacokinetic and pharmacodynamic characteristics. Yang M; Gu Y; Yang D; Tang X; Liu J J Nanobiotechnology; 2017 Dec; 15(1):88. PubMed ID: 29202753 [TBL] [Abstract][Full Text] [Related]
15. Pharmacokinetics and tissue distribution study in mice of triptolide-loaded lipid emulsion and accumulation effect on pancreas. Li X; Mao Y; Li K; Shi T; Yao H; Yao J; Wang S Drug Deliv; 2016 May; 23(4):1344-54. PubMed ID: 25853479 [TBL] [Abstract][Full Text] [Related]
16. pH-sensitive nanoformulated triptolide as a targeted therapeutic strategy for hepatocellular carcinoma. Ling D; Xia H; Park W; Hackett MJ; Song C; Na K; Hui KM; Hyeon T ACS Nano; 2014 Aug; 8(8):8027-39. PubMed ID: 25093274 [TBL] [Abstract][Full Text] [Related]
17. Enhancement of triptolide-loaded micelles on tumorigenicity inhibition of human ovarian cancer. Wang Y; Liu T; Li H J Biomater Sci Polym Ed; 2016; 27(7):545-56. PubMed ID: 26786618 [TBL] [Abstract][Full Text] [Related]
18. Sun R; Fang L; Lv X; Fang J; Wang Y; Chen D; Wang L; Chen J; Qi Y; Tang Z; Zhang J; Tian Y Drug Deliv; 2021 Dec; 28(1):2071-2084. PubMed ID: 34595970 [TBL] [Abstract][Full Text] [Related]
19. Anti-tumour and immuno-modulation effects of triptolide-loaded polymeric micelles. Xu L; Chen H; Xu H; Yang X Eur J Pharm Biopharm; 2008 Nov; 70(3):741-8. PubMed ID: 18761405 [TBL] [Abstract][Full Text] [Related]
20. Norcantharidin-associated galactosylated chitosan nanoparticles for hepatocyte-targeted delivery. Wang Q; Zhang L; Hu W; Hu ZH; Bei YY; Xu JY; Wang WJ; Zhang XN; Zhang Q Nanomedicine; 2010 Apr; 6(2):371-81. PubMed ID: 19699319 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]